| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.761 | 1.504 | 1.767 | 1.488 | 2.599 | 1.806 | 3.865 | 2.828 | 957 | 1.932 |
| Total Income - EUR | 3.762 | 1.503 | 1.767 | 1.490 | 2.599 | 1.910 | 3.865 | 2.828 | 957 | 1.932 |
| Total Expenses - EUR | 2.140 | 2.467 | 1.822 | 1.642 | 1.454 | 2.318 | 2.695 | 1.430 | 1.644 | 1.653 |
| Gross Profit/Loss - EUR | 1.622 | -964 | -55 | -151 | 1.144 | -408 | 1.170 | 1.398 | -688 | 279 |
| Net Profit/Loss - EUR | 1.509 | -1.009 | -107 | -196 | 1.067 | -461 | 1.054 | 1.339 | -688 | 236 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Qualmed Consulting Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 453 | 263 | 76 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 303 | 552 | 390 | 202 | 133 | 133 | 1.555 | 2.977 | 1.571 | 2.562 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 25 | 68 | 0 | 7 | 7 | 2 | 43 | 63 | 210 | 308 |
| Cash | 279 | 485 | 390 | 196 | 127 | 131 | 1.512 | 2.914 | 1.362 | 2.254 |
| Shareholders Funds | 308 | -704 | -800 | -981 | 105 | -350 | 713 | 2.054 | 1.361 | 1.589 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 562 | 1.670 | 1.365 | 1.319 | 29 | 483 | 842 | 922 | 211 | 973 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Qualmed Consulting Srl